LAI approved by FDA for schizophrenia and bipolar disorder
Schizophrenia and bipolar I disorder patients can be offered Rykindo® as a bi-weekly extended-release injectable, now FDA approved.
Source: europeanpharmaceuticalreview.com
Luye Pharmaceutical News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Luye Pharmaceutical. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Luye Pharmaceutical Today - Breaking & Trending Today
Luye Pharma: Genau das was haben wir angekündigt ()
Luye Pharma: Wer hätte das gedacht? () | aktiencheck.de
Source: aktiencheck.de